The biological sample procurement company iSpecimen plans to establish a $200 million cryptocurrency asset pool by purchasing SOL through OTC

ChainCatcher news, according to Investing, the biosample procurement company iSpecimen Inc. (ISPC) announced that several cryptocurrency companies have approached it to provide investment opportunities. The company is planning to establish a digital asset portfolio valued at $200 million, aimed at diversifying its balance sheet and supporting growth plans through tokenized real-world assets and top-ranked cryptocurrencies.

iSpecimen is continuing parallel discussions to develop a financial plan based on the Solana blockchain. The company plans to purchase SOL through over-the-counter transactions with cryptocurrency institutions, including locked SOL with contract transfer or vesting restrictions.